Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study.
Related Research units
Abstract
Bibliographical data
Original language | English |
---|---|
Article number | 5 |
ISSN | 2152-2650 |
Publication status | Published - 2011 |
pubmed | 21729686 |
---|